2001
DOI: 10.1016/s0039-128x(00)00215-4
|View full text |Cite
|
Sign up to set email alerts
|

Suppressing aggressive behavior with analogs of allopregnanolone (epalon)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2005
2005
2020
2020

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 13 publications
(16 citation statements)
references
References 21 publications
0
13
0
Order By: Relevance
“…In some studies the antiaggressive effect of atypical neuroleptics was not accompanied by the decrease of locomotion [Aguilar et al, 1994;Redolat et al, 1991]. Next, the benzodiazepine receptor partial agonist Ro 19-8022 was found to have anxiolytic-like and potent antiaggressive effects without causing muscle relaxation or ataxia [Podhorna and Krsiak, 2000] and a pattern of increased aggression after low doses and decreased after high doses can be seen after neurosteroides administration [Miczek et al, 2003;Slavikova et al, 2001]. The selective decrease of aggression was also observed after the treatment of nicotinic agonists lobeline [Redolat et al, 2002] and delta9-tetrahydrocannabinol [Miczek, 1978].…”
Section: Discussionmentioning
confidence: 99%
“…In some studies the antiaggressive effect of atypical neuroleptics was not accompanied by the decrease of locomotion [Aguilar et al, 1994;Redolat et al, 1991]. Next, the benzodiazepine receptor partial agonist Ro 19-8022 was found to have anxiolytic-like and potent antiaggressive effects without causing muscle relaxation or ataxia [Podhorna and Krsiak, 2000] and a pattern of increased aggression after low doses and decreased after high doses can be seen after neurosteroides administration [Miczek et al, 2003;Slavikova et al, 2001]. The selective decrease of aggression was also observed after the treatment of nicotinic agonists lobeline [Redolat et al, 2002] and delta9-tetrahydrocannabinol [Miczek, 1978].…”
Section: Discussionmentioning
confidence: 99%
“…In line with the above studies, Covey and coworkers prepared and evaluated a series of 13,24-cyclo-18,21-dinorcholanes containing a ketone or a conjugated ketone group at C-20, C-22, C-23 or C-24 (30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42)(43)(44)(45) [28]. These ana- logues with conformationally constrained side chains were used to gain new information concerning the optimal location(s) for a hydrogen bond accepting group on the D-ring.…”
Section: Modifications At the D Ring And The Side Chainmentioning
confidence: 95%
“…Kasal and coworkers prepared the 3 -fluoro analogues (194 and 198) of allopregnanolone (1) and pregnanolone (2) respectively, taking into account that the strength of the C-F bond yielded products with a high metabolic stability [41,42]. Although the results of binding assays in vitro (using [ 3 H]muscimol and [ 35 S]TBPS) showed that the replacement of the 3 -hydroxyl by a 3 -fluoro gave a small loss in activity, compound 194 showed stronger antiaggressive effects than allopregnanolone (1) in a behavioral test with mice [42].…”
Section: The Data Inmentioning
confidence: 99%
“…8,9 Neurosteroids, such as 3R-hydroxy-5R-pregnan-20-one (allopregnanolone, 1), 3R-hydroxy-5 -pregnan-20-one (pregnanolone, 2), and their 21-hydroxy derivatives, that is, 3R,21-dihydroxy-5R-pregnan-20-one (allotetrahydrodeoxycorticosterone, 3) and 3R,21-dihydroxy-5 -pregnan-20-one (tetrahydrodeoxycorticosterone, 4), have been proven to be anticonvulsant, anesthetic, antidepressant, and neuroprotectant agents. [10][11][12][13][14][15][16][17][18] In vitro assays reflect this positive modulation by showing an increase of both the Cl -influx through the GABA A receptor and the binding of GABA agonists or benzodiazepines. 8,14,15,[19][20][21][22][23] Although acting at higher concentrations than benzodiazepines and barbiturates, neurosteroids are valued 24 because they combine the effects of both and have fewer and less severe side effects.…”
Section: Introductionmentioning
confidence: 99%